Recombinant Cytochrome P450 Hydroxylase for Delta-Lactone Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing delta-lactones are inefficient, resulting in low yields and high costs, and rely on plant extraction or chemical synthesis, which have environmental and consumer preference limitations.

Innovation Solution

A novel biosynthetic process using recombinant cytochrome P450 hydroxylase enzymes with specific amino acid substitutions to convert carboxylic acids into delta-lactones through a one-step batch fermentation process, achieving higher yields and purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If plant extraction methods are used to produce delta-lactones, then natural compounds can be obtained, but production efficiency is low and costs are high

Engineering Contradiction:
Improvequality of natural compoundVSAvoidproduction efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent modifies the cytochrome P450 hydroxylase enzyme through site-directed mutagenesis, changing specific amino acid residues (e.g., F87A, F87L, F87W substitutions) to alter the enzyme's substrate binding pocket. This parameter change in the enzyme structure enables it to specifically hydroxylate fatty acids at the delta position, thereby producing delta-lactones with high selectivity and efficiency through fermentation, resolving the contradiction between obtaining natural compounds and maintaining high productivity

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If chemical synthesis methods are used to produce delta-lactones, then production costs can be reduced, but consumer preference for natural compounds decreases

Engineering Contradiction:
Improveproduction costVSAvoidconsumer acceptance as natural compound
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent replaces chemical synthesis mechanisms with biological enzymatic mechanisms. By using engineered cytochrome P450 hydroxylase enzymes in a fermentation process, the method produces delta-lactones through a biological pathway that consumers recognize as natural, while still achieving cost-effective production through efficient enzymatic catalysis and scalable fermentation technology

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If traditional biosynthetic methods are used, then natural compound production is achieved, but yields are low and processes are inefficient

Engineering Contradiction:
Improvenatural compound productionVSAvoidyield and efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent systematically modifies key parameters of the cytochrome P450 hydroxylase enzyme through site-directed mutagenesis. Specific amino acid substitutions (such as F87A, F87L, F87W at position 87, and other residues in the substrate binding pocket) are introduced to change the enzyme's catalytic properties and substrate specificity. These parameter changes enable the enzyme to efficiently produce delta-lactones with high yields through a one-step fermentation process, resolving the contradiction between natural compound production and productivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The engineered cytochrome P450 hydroxylase enzyme serves as a biological intermediary that converts readily available fatty acid substrates into valuable delta-lactone products. This intermediary enzyme system enables efficient transformation through fermentation, bridging the gap between simple substrates and complex natural compounds while achieving high productivity

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process enables the reliable and cost-effective production of delta-lactones with high purity, addressing the inefficiencies of traditional methods and aligning with consumer demand for natural, 'nature-identical' compounds.

Implementation Method 1

recombinant cytochrome P450 hydroxylase enzymes with specific amino acid substitutions to convert carboxylic acids into delta-lactones

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

cytochrome p450 hydroxylase enzymes or mutants thereof... perform δ-hydroxylation on fatty acids

Methodology Applied
Scientific EffectHydroxylation: Oxidation

Implementation Method 3

convert fatty acids to delta-lactones... convert a carboxylic acid into its corresponding delta-lactone

Methodology Applied
Scientific EffectCyclization:

Implementation Method 4

production of delta-lactone compounds via a one-step batch fermentation process

Methodology Applied
Scientific EffectEsterification: Chemical Bonding

Implementation Method 5

production of delta-lactone compounds via a one-step batch fermentation process

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS20240327368A1Biosynthetic production of gamma- or delta-lactones using cytochrome p450 hydroxylase enzymes or mutants thereof
Publication Date: 2024.10.03 CONAGEN INC
  • US20240327368A1 patent drawing
  • US20240327368A1 patent drawing
  • US20240327368A1 patent drawing

AI summary

The present disclosure relates, at least in part, to the production of delta-lactones and gamma-lactones from fatty acid substrates (e.g., fatty acid substrates of C16-C25) via a batch fermentation method in an engineered microbe using a recombinant cytochrome P450 monooxygenase.